Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Mid Cap Fund median (32 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 02 Jan 2013 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Midcap 150 history starts 14 Jan 2019, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI Midcap Fund |
|---|---|
| 02 Jan 2013 | ₹100.00 |
| 21 Feb 2014 | ₹114.90 |
| 12 Apr 2015 | ₹182.58 |
| 31 May 2016 | ₹197.92 |
| 19 Jul 2017 | ₹226.09 |
| 07 Sep 2018 | ₹213.95 |
| 27 Oct 2019 | ₹191.48 |
| 15 Dec 2020 | ₹255.89 |
| 03 Feb 2022 | ₹407.76 |
| 25 Mar 2023 | ₹406.49 |
| 12 May 2024 | ₹605.50 |
| 01 Jul 2025 | ₹708.57 |
| 20 Aug 2026 | ₹725.53 |
| Metric | SBI · Direct · IDCW NAV ₹155.84 Very High risk ★★★☆☆ | Category median Mid Cap Fund · 32 funds |
|---|---|---|
| +6.29% | +6.29% | |
| +13.75% | +14.78% | |
| +15.70% | +13.99% | |
| +13.84% | +9.73% | |
| +15.65% | +15.68% | |
| +12.84% | — | |
| +16.53% | +16.53% | |
| +15.57% | +14.94% | |
| +15.59% | +12.00% | |
| Risk | ||
| 13.38% | 16.93% | |
| 0.54 | 0.53 | |
| 0.73 | 0.73 | |
| -46.01% | -36.26% | |
| Nifty Midcap 150 | — | |
| -2.79% | -2.10% | |
| 0.85 | 0.97 | |
| 78.6% | 93.0% | |
| 83.8% | 95.9% | |
| 0.98% | 0.95% | |
| ₹22,745Cr | ₹7,889Cr | |
| Up to 0.25% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 33% | 40% | |
| Pradeep Kesavan · 2.7y | — | |
| 02 Jan 2013 | — | |
| 55 | — | |
| 27.5% | — | |
| 0.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.